Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 12/2011

01-12-2011 | Original paper

Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999–2004

Authors: Charlene A. Wong, Melissa A. Jim, Jessica King, Lillian Tom-Orme, Jeffrey A. Henderson, Mona Saraiya, Lisa C. Richardson, Larry Layne, Anil Suryaprasad, David K. Espey

Published in: Cancer Causes & Control | Issue 12/2011

Login to get access

Abstract

Objective

To present more accurate incidence rates of cervical, uterine, and ovarian cancer by geographic region in American Indian/Alaska Native (AI/AN) women.

Methods

The authors used data from central cancer registries linked to Indian Health Service (IHS) patient registration database, the Behavioral Risk Factor Surveillance System, IHS National Data Warehouse, and the National Hospital Discharge Survey. Cancer incidence rates were adjusted for hysterectomy and oophorectomy prevalence and presented by region for non-Hispanic White (NHW) and AI/AN women.

Results

AI/AN women had a higher prevalence of hysterectomy (23.1%) compared with NHW women (20.9%). Correcting cancer rates for population-at-risk significantly increased the cancer incidence rates among AI/AN women: 43% for cervical cancer, 67% for uterine cancer, and 37% for ovarian cancer. Risk-correction led to increased differences in cervical cancer incidence between AI/AN and NHW women in certain regions.

Conclusions

Current reporting of cervical, uterine, and ovarian cancer underestimates the incidence in women at risk and can affect the measure of cancer disparities. Improved cancer surveillance using methodology to correct for population-at-risk may better inform disease control priorities for AI/AN populations.
Literature
1.
Merrill RM, Feuer EJ (1996) Risk-adjusted cancer-incidence rates (United States). Cancer Causes Control 7(5):544–552PubMedCrossRef
2.
Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B et al (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 296(2):185–192PubMedCrossRef
3.
4.
Merrill RM, Layman AB, Oderda G, Asche C (2008) Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy. Ann Epidemiol 18(3):253–260PubMedCrossRef
5.
Luoto R, Raitanen J, Pukkala E, Anttila A (2004) Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953–2010. Br J Cancer 90(9):1756–1759PubMedCrossRef
6.
Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA (2002) Hysterectomy surveillance—United States, 1994–1999. MMWR CDC Surveill Summ 51:1–8
7.
Merrill RM (2006) Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States. Ann Epidemiol 16(12):880–887PubMedCrossRef
8.
Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG (2007) Hysterectomy rates in the United States, 2003. Obstet Gynecol 110(5):1091–1095PubMedCrossRef
9.
Zhang Y, Lee ET, Cowan LD, North KE, Wild RA, Howard BV (2005) Hysterectomy prevalence and cardiovascular disease risk factors in American Indian women. Maturitas 52(3–4):328–336PubMedCrossRef
10.
Alderson M, Donnan S (1978) Hysterectomy rates and their influence upon mortality from carcinoma of the cervix. J Epidemiol Community Health 32(3):175–177PubMedCrossRef
11.
Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 15:2119–2152CrossRef
12.
Wiggins CL, Espey DK, Wingo PA, Kaur JS, Wilson RT, Swan J et al (2008) Cancer among American Indians and Alaska Natives in the United States, 1999–2004. Cancer 113(5 Suppl):1142–1152PubMedCrossRef
13.
Behavioral Risk Factor Surveillance System. Hysterectomy status by state, race/ethnicity, and age, 1996–2000. Survey Data, National Center for Chronic Disease Prevention and Health Promotion, Centers of Disease Control and Prevention, US Department of Health and Human Services. Available from: http://​www.​nuff.​org/​health_​hysterectomystat​istics2.​htm. Last accessed 10 June 2010
14.
Howard BV, Kuller L, Langer R, Manson JE, Allen C, Assaf A et al (2005) Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women’s Health Initiative Observational Study. Circulation 111(12):1462–1470PubMedCrossRef
15.
Fritz A, Percy C, Jack A (2000) International classification of diseases of oncology. World Health Organization, Geneva
16.
US Cancer Statistics Working Group (2007) United States cancer statistics: 2004 incidence. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta
17.
Espey DK, Wiggins CL, Jim MA, Miller BA, Johnson CJ, Becker TM (2008) Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer 113(5 Suppl):1120–1130PubMedCrossRef
18.
Centers for Disease Control, Prevention (2003) Public health surveillance for behavioral risk factors in a changing environment: recommendations from the Behavioral Risk Factor Surveillance Team. MMWR Morb Mortal Wkly Rep 52:1–11
19.
20.
21.
22.
23.
Anderson R, Rosenberg H (1998) Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 47(3):16
24.
Tiwari RC, Clegg LX, Zou Z (2006) Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 15(6):547–569PubMedCrossRef
25.
Becker TM, Espey DK, Lawson HW, Saraiya M, Jim MA, Waxman AG (2008) Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999–2004. Cancer 113(5 Suppl):1234–1243PubMedCrossRef
26.
Lawrence J (2000) The Indian Health Service and the sterilization of Native American women. Am Indian Q 24(3):400–419PubMedCrossRef
27.
Brett KM, Marsh JV, Madans JH (1997) Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample. J Womens Health 6(3):309–316PubMedCrossRef
28.
Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110(10):2119–2152PubMedCrossRef
29.
Erekson EA, Weitzen S, Sung VW, Raker CA, Myers DL (2009) Socioeconomic indicators and hysterectomy status in the United States, 2004. J Reprod Med 54(9):553–558PubMed
30.
Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM et al (2008) Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 198(1):34.e1–34.e7CrossRef
31.
Luman ET, Ryman TK, Sablan M (2009) Estimating vaccination coverage: validity of household-retained vaccination cards and parental recall. Vaccine 27(19):2534–2539PubMedCrossRef
32.
Espey D, Paisano R, Cobb N (2005) Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990–2001. Cancer 103(5):1045–1053PubMedCrossRef
33.
Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ et al (2003) American Cancer Society guideline for the early detection of cervical neoplasia and cancer. J Low Genit Tract Dis 7(2):67–86PubMedCrossRef
34.
ACOG Practice Bulletin No. 109 (2009) Cervical cytology screening. Obstet Gynecol 114(6):1409–1420
35.
Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA (2000) Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 88(10):2283–2289PubMedCrossRef
36.
Steele CB, Cardinez CJ, Richardson LC, Tom-Orme L, Shaw KM (2008) Surveillance for health behaviors of American Indians and Alaska Natives-findings from the behavioral risk factor surveillance system, 2000–2006. Cancer 113(5 Suppl):1131–1141PubMedCrossRef
37.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 56(RR-2):1–24PubMed
38.
US Cancer Statistics Working Group (2010) United States cancer statistics: 1999–2006 incidence and mortality web-based report. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute, Atlanta. Available from: http://​www.​cdc.​gov/​uscs. Last accessed 10 June 2010
39.
Schiff M, Key CR, Gilliland FD, Becker TM (1997) Ethnic differences in uterine corpus cancer incidence and mortality in New Mexico’s American Indians, hispanics and non-Hispanic whites. Int J Epidemiol 26(2):249–255PubMedCrossRef
40.
Sabatino SA, Stewart SL, Wilson RJ (2009) Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001–2003. J Womens Health (Larchmt) 18(3):285–294CrossRef
41.
Lyon JL, Gardner JW (1977) The rising frequency of hysterectomy: its effect on uterine cancer rates. Am J Epidemiol 105(5):439–443PubMed
42.
Weiss JM, Saltzman BS, Doherty JA, Voigt LF, Chen C, Beresford SA et al (2006) Risk factors for the incidence of endometrial cancer according to the aggressiveness of disease. Am J Epidemiol 164(1):56–62PubMedCrossRef
43.
Welty TK, Lee ET, Yeh J, Cowan LD, Go O, Fabsitz RR et al (1995) Cardiovascular disease risk factors among American Indians. The Strong Heart Study. Am J Epidemiol 142(3):269–287PubMed
44.
45.
Hicks ML, Phillips JL, Parham G, Andrews N, Jones WB, Shingleton HM et al (1998) The National Cancer Data Base report on endometrial carcinoma in African–American women. Cancer 83(12):2629–2637PubMedCrossRef
46.
North KE, MacCluer JW, Cowan LD, Howard BV (2000) Gravidity and parity in postmenopausal American Indian women: the Strong Heart Study. Hum Biol 72(3):397–414PubMed
47.
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366(9484):491–505PubMedCrossRef
48.
Goodman MT, Howe HL, Tung KH, Hotes J, Miller BA, Coughlin SS et al (2003) Incidence of ovarian cancer by race and ethnicity in the United States, 1992–1997. Cancer 97(10 Suppl):2676–2685PubMedCrossRef
49.
Saraiya M, Lee NC, Blackman D, Smith MJ, Morrow B, McKenna MA (2001) Self-reported Papanicolaou smears and hysterectomies among women in the United States. Obstet Gynecol 98(2):269–278PubMedCrossRef
50.
Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA et al (1997) Hysterectomy surveillance—United States, 1980–1993. MMWR CDC Surveill Summ 46(4):1–15PubMed
51.
52.
Lowder JL, Oliphant SS, Ghetti C, Burrows LJ, Meyn LA, Balk J (2010) Prophylactic bilateral oophorectomy or removal of remaining ovary at the time of hysterectomy in the United States, 1979–2004. Am J Obstet Gynecol 202(6):538.e1–538.e9
53.
Howe HL (1984) Age-specific hysterectomy and oophorectomy prevalence rates and the risks for cancer of the reproductive system. Am J Public Health 74(6):560–563PubMedCrossRef
54.
Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z et al (2009) Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses’ health study. Obstet Gynecol 113(5):1027–1037PubMed
55.
56.
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765PubMedCrossRef
Metadata
Title
Impact of hysterectomy and bilateral oophorectomy prevalence on rates of cervical, uterine, and ovarian cancer among American Indian and Alaska Native women, 1999–2004
Authors
Charlene A. Wong
Melissa A. Jim
Jessica King
Lillian Tom-Orme
Jeffrey A. Henderson
Mona Saraiya
Lisa C. Richardson
Larry Layne
Anil Suryaprasad
David K. Espey
Publication date
01-12-2011
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 12/2011
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9844-2

Other articles of this Issue 12/2011

Cancer Causes & Control 12/2011 Go to the issue

Original paper

The influence of physicians on colorectal cancer screening behavior

Original paper

Occupational exposure to metal compounds and lung cancer. Results from a multi-center case–control study in Central/Eastern Europe and UK

Original paper

Fruit and vegetable consumption is inversely associated with having pancreatic cancer

Original Paper

Timing and intensity of recreational physical activity and the risk of subsite-specific colorectal cancer

Original paper

Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer

Original paper

A prospective study of intakes of zinc and heme iron and colorectal cancer risk in men and women
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits